Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer

Archives of Medical Research

Volumn 45, Issue 6, 2014, Pages 445-454

  Cincin, Zeynep Birsu ^a   Unlu, Miray ^b   Kiran, Bayram ^c   Bireller, Elif Sinem ^a   Baran, Yusuf ^b   Cakmakoglu, Bedia ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

^c KASTAMONU UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Microarray; Non small cell lung cancer; Quercitrin

Indexed keywords

CASPASE 3; LACTATE DEHYDROGENASE; PHOSPHATIDYLSERINE; QUERCITRIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; QUERCETIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NON SMALL CELL LUNG CANCER; WST-1 ASSAY; ANALOGS AND DERIVATIVES; CARCINOMA, NON-SMALL-CELL LUNG; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; EVALUATION STUDY; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; QUERCETIN;

EID: 84908073606     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.08.002     Document Type: Article

References (22)

1. Pao W., Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol 2011, 12:175-180.
2. Travis W.D. Classification of lung cancer. Semin Roentgenol 2011, 46:178-186.
3. Brognard J., Clark A.S., Ni Y., et al. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001, 61:3986-3997.
4. Schiller J.H. Current standards of care in small-cell and non-small-cell lung cancer. Oncology 2001, 1:3-13.
5. Gottschling S., Schnabel P.A., Herth F.J., et al. Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer. Cancer Genomics Proteomics 2012, 9:275-286.
6. Denlinger C.E., Ikonomidis J.S., Reed C.E., et al. Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers. J Thorac Cardiovasc Surg 2010, 140:505-513.
7. Goeckenjan G., Sitter H., Thomas M., et al. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie 2011, 65:39-59. German Respiratory Society;German Cancer Society.
8. Burris H.A. Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs. Oncogene 2009, 1:4-13.
9. Giaccone G. Twenty-five years of treating advanced NSCLC: what have we achieved?. Ann Oncol 2004, 4:81-83.
10. Neal J.W., Sequist L.V. Exciting new targets in lung cancer therapy: ALK, IGF-1R, HDAC, and Hh. Curr Treat Options Oncol 2011, 11:36-44.
11. Sangha R., Lara P.N., Mack P.C., et al. Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier. Curr Opin Oncol 2009, 21:116-123.
12. Mateen S., Raina K., Agarwal R. Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer. Nutr Cancer 2013, 1:3-11.
13. Nones J.E., Spohr T.C., Gomes F.C. Quercitrin, a flavone glycoside, as mediator of neuronal survival. Neurochem Res 2011, 36:1776-1784.
14. Tanaka T., Takahashi R. Flavonoids and asthma. Nutrients 2013, 5:2128-2143.
15. Ding M., Zhao J., Bowman L., et al. Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrin. Int J Oncol 2010, 36:59-67.
16. Gee J.M., DuPont M.S., Rhodes M.J., et al. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic Biol Med 1998, 25:19-25.
17. Wagner C., Fachinetto R., Dalla Corte C.L., et al. Quercitrin, a glycoside form of quercetin, prevents lipid peroxidation invitro. Brain Res 2006, 1107:192-198.
18. Cruz E.A., Da-Silva S.A., Muzitano M.F., et al. Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock. Int Immunopharmacol 2008, 8:1616-1621.
19. Yang H.M., Ham Y.M., Yoon W.J., et al. Quercitrin protects against ultraviolet B-induced cell death invitro and in an invivo zebrafish model. J Photochem Photobiol B 2012, 114:126-131.
20. Browning A.M., Walle U.K., Walle T. Flavonoid glycosides inhibit oral cancer cell proliferation role of cellular uptake and hydrolysis to the aglycones. J Pharm Pharmacol 2005, 57:1037-1042.
21. Xu R., Zhang Y., Ye X., et al. Inhibition effects andinduction of apoptosis of flavonoids on the prostate cancer cell line PC-3 invitro. Food Chem 2013, 138:48-53.
22. Zheng S.Y., Li Y., Jiang D., et al. Anticancer effect and apoptosis induction by quercetin in the human lung cancer cell line A-549. Mol Med Rep 2012, 5:822-826.